Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saad Z Usmani

Showing results (41-50 of 253) with videos related to

Pageof 26
Sort By:
Expert Opinion on Biological Therapy|August 5, 2020
Daratumumab subcutaneous formulation for the treatment of multiple myelomaBarry Paul, Issam Hamadeh, Shebli Atrash, et al.
Leukemia|November 29, 2019
Extramedullary multiple myelomaManisha Bhutani, David M Foureau, Shebli Atrash, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 29, 2023
Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple MyelomaSagar Lonial, Andrew D Bowser, Ajai Chari, et al.
Acta Haematologica|May 22, 2013
Waldenström's macroglobulinemia associated with serum amyloid A protein amyloidosis: pitfalls in diagnosis and successful treatment with melphalan-based autologous stem cell transplantJameel Muzaffar, Lakshmikanth Katragadda, Sajjad Haider, et al.
Expert Review of Hematology|October 30, 2016
The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemiaRyan W Jacobs, Farrukh T Awan, Lori A Leslie, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 18, 2016
Practical Considerations in Managing Relapsed Multiple MyelomaAmit Agarwal, Eric Chow, Manisha Bhutani, et al.
Seminars in Hematology|January 29, 2014
Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin lymphomasMehdi Hamadani, Sarah M Abu Kar, Saad Z Usmani, et al.
Experimental Hematology & Oncology|February 16, 2018
Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myelomaSaad Z Usmani, Imran Khan, Christopher Chiu, et al.
Journal of Geriatric Oncology|February 3, 2019
Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United StatesShuling Li, Tanya Natwick, Jiannong Liu, et al.
Blood Cancer Journal|July 17, 2023
Global disparities in patients with multiple myeloma: a rapid evidence assessmentMaria-Victoria Mateos, Sikander Ailawadhi, Luciano J Costa, et al.
Pageof 26

Showing results (41-50 of 253) with videos related to

Sort By:
Pageof 26
Expert Opinion on Biological Therapy|August 5, 2020
Daratumumab subcutaneous formulation for the treatment of multiple myelomaBarry Paul, Issam Hamadeh, Shebli Atrash, et al.
Leukemia|November 29, 2019
Extramedullary multiple myelomaManisha Bhutani, David M Foureau, Shebli Atrash, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 29, 2023
Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple MyelomaSagar Lonial, Andrew D Bowser, Ajai Chari, et al.
Acta Haematologica|May 22, 2013
Waldenström's macroglobulinemia associated with serum amyloid A protein amyloidosis: pitfalls in diagnosis and successful treatment with melphalan-based autologous stem cell transplantJameel Muzaffar, Lakshmikanth Katragadda, Sajjad Haider, et al.
Expert Review of Hematology|October 30, 2016
The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemiaRyan W Jacobs, Farrukh T Awan, Lori A Leslie, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 18, 2016
Practical Considerations in Managing Relapsed Multiple MyelomaAmit Agarwal, Eric Chow, Manisha Bhutani, et al.
Seminars in Hematology|January 29, 2014
Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin lymphomasMehdi Hamadani, Sarah M Abu Kar, Saad Z Usmani, et al.
Experimental Hematology & Oncology|February 16, 2018
Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myelomaSaad Z Usmani, Imran Khan, Christopher Chiu, et al.
Journal of Geriatric Oncology|February 3, 2019
Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United StatesShuling Li, Tanya Natwick, Jiannong Liu, et al.
Blood Cancer Journal|July 17, 2023
Global disparities in patients with multiple myeloma: a rapid evidence assessmentMaria-Victoria Mateos, Sikander Ailawadhi, Luciano J Costa, et al.
Pageof 26